Table 4. Characteristics of patients according to mortality.

Characteristics	Death during follow-up (n=38)	Alive at follow-up (n=446)	p-value
Age (yr)	65.9±10.2	62.4±10.5	0.051
Sex (male)	31 (81.6)	356 (79.8)	0.795
High-intensity statin at discharge	33 (86.8)	392 (87.9)	0.849
Statin plus ezetimibe at discharge	2 (5.3)	55 (12.3)	0.293
High-intensity statin plus ezetimibe at discharge	2 (5.3)	44 (9.9)	0.563
LDL-C at follow-up (mmol/L)	1.91±0.90	1.93±0.91	0.875
LDL-C at follow-up (mg/dL)	73.8±34.9	74.7±35.0	0.875
LDL-C <1.4 mmol/L (54 mg/dL) at follow-up	11 (28.9)	107 (24.0)	0.495
LDL-C <1.8 mmol/L (70 mg/dL) at follow-up	22 (57.9)	209 (46.9)	0.191

Data are presented as mean±standard deviation or count (percent).

HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.